Download PDF
Thromb Haemost 1984; 52(01): 090-093
DOI: 10.1055/s-0038-1661144
Original Article
Schattauer GmbH Stuttgart

Acquired von Willebrand’s Syndrome Associated with Hydatid Disease of the Spleen – Disappearance after Splenectomy

C Richard
The Haematology Department, Marqués de Valdecilla National Medical Centre, Santander, Spain
,
M C Sedano
The Haematology Department, Marqués de Valdecilla National Medical Centre, Santander, Spain
,
M A Cuadrado
The Haematology Department, Marqués de Valdecilla National Medical Centre, Santander, Spain
,
M Recio
The Haematology Department, Marqués de Valdecilla National Medical Centre, Santander, Spain
,
V Hermosa
The Haematology Department, Marqués de Valdecilla National Medical Centre, Santander, Spain
,
A Zubizarreta
The Haematology Department, Marqués de Valdecilla National Medical Centre, Santander, Spain
› Author Affiliations
Further Information

Publication History

Received 29 December 1983

Accepted 20 March 1984

Publication Date:
19 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

A new case of acquired von Willebrand’s syndrome (vWS) is described in a 31-year-old woman with a hydatid splenomegaly and with a history of repeated abortions at an advanced stage of pregnancy, a positive serology for syphilis and a mildly elevated titre of antinuclear antibodies, with no family history of bleeding.

There is an inhibitory effect on factor VIII: C (antihaemophilic factor) as well as on factor VIIIR: Ag (related antigen) and on factor VIIIR:RCo (ristocetin cofactor), and it is precipitated by rabbit anti-IgG antiserum. This inhibitory effect was demonstrated using the patient’s plasma heated to 56° C for one hour so as to dissociate circulating immunocomplexes.

All the abnormalities of haemostasis, as well as the positive serology for syphilis, disappeared after splenectomy, and the ANA titre reverted to normal.

The clinical and biological peculiarities of the case are discussed, and are interpreted in the light of the findings recorded in patients showing “lupus” anticoagulant.

Keywords

Acquired von Willebrand’s syndrome - Auto-antibody
 

  • References

  • 1 Simone JV, Cornet JA, Abildgaard CF. Acquired von Willebrand’s syndrome in systemic lupus erythematosus. Blood 1968; 31: 806-812
    PubMedGoogle Scholar
  • 2 Veltkamp JJ, Stevens P, Plas MV D, Loeliger EA. Production site of bleeding factor (acquired morbus von Willebrand). Thrombos Diathes Haemorrh 1970; 23: 412
    PubMedGoogle Scholar
  • 3 Ingram GI C, Kingston PJ, Leslie J, Bowie EJ W. Four cases of acquired von Willebrand’s syndrome. Br J Haematol 1971; 21: 189-199
    CrossrefPubMedGoogle Scholar
  • 4 Mant MJ, Hirsh H, Gauldie J, Bienenstock J, Pineo GF, Luke KH. Von Willebrand’s syndrome presenting as an acquired bleeding disorder in association with a monoclonal gammapathy. Blood 1973; 42: 429-436
    PubMedGoogle Scholar
  • 5 Poole-Wilson PA. Acquired von Willebrand’s syndrome and systemic lupus erythematosus. Proc Soc Med 1972; 65: 7-8
    PubMedGoogle Scholar
  • 6 Leone G, Pola P, Guerrera G, Bizzi B. Acquired von Willebrand’s syndrome during collagen disorder. Haematologica 1974; 59: 212-220
    PubMedGoogle Scholar
  • 7 Handin RI, Martin V, Moloney WC. Antibody-induced von Willebrands disease: a newly defined inhibitor syndrome. Blood 1976; 48: 393-406
    PubMedGoogle Scholar
  • 8 Wautier JL, Levy-Toledano S, Caen J. Acquired von Willebrand’s syndrome and thrombopathy in a patient with chronic lymphocytic leukaemia. Scand J Haematol 1976; 16: 128-134
    PubMedGoogle Scholar
  • 9 Stableforth P, Tamagnini GL, Dormandy KM. Acquired von Willebrand’s syndrome with inhibitors both to factor VIII clotting activity and Ristocetin-induced platelet aggregation. Br J Haematol 1976; 33: 565-573
    CrossrefPubMedGoogle Scholar
  • 10 Rosborough TK, Seaim WR. Acquired von Willebrand’s disease, platelet release defect and angiodysplasia. Am J Med 1978; 65: 96-100
    CrossrefPubMedGoogle Scholar
  • 11 Joist JH, Cowan JF, Zimmerman TS. Acquired von Willebrand’s disease. Evidence for a quantitative and qualitative factor VIII disorder N Eng J Med 1978; 7: 988-991
    PubMedGoogle Scholar
  • 12 Gazengel C, Prieur AM, Jacques C, Buriot D, Nedellec J, Josso F. Antibody-induced von Willebrand’s syndrome inhibition of VIII/vWF and VIIIR:Ag with sparing of VIII :C by the auto-antibody. Am J Hematol 1978; 5: 355-363
    CrossrefPubMedGoogle Scholar
  • 13 Zetterwall O, Nilsson IM. Acquired von Willebrand’s Disease Caused by a Monoclonal Antibody. Acta Med Scand 1978; 204: 521-528
    PubMedGoogle Scholar
  • 14 Clough V, MacFarlane IA, O’Connor J, Wood JK. Acquired von Willebrand’s Syndrome and Ehlers-Danlos Syndrome Presenting with Gastro-Intestinal Bleeding. Scand J Haematol 1979; 22: 305-310
    PubMedGoogle Scholar
  • 15 Meyer D, Frommel D, Larrieu MJ, Zimmerman TS. Selective Absence of Large Forms of Factor VIII/von Willebrand Factor in Acquired von Willebrand’s Syndrome. Response to Transfusion. Blood 1979; 54: 600-606
    PubMedGoogle Scholar
  • 16 Brody JI, Haidar ME, Rossman RE. A Hemorrhagic syndrome in Waldenstrom’s macroglobulinemia secondary to immunoadsorption of Factor VIII. Recovery after splenectomy N Engl J Med 1979; 300: 408-410
    CrossrefPubMedGoogle Scholar
  • 17 Roussi JH, Joubouyan LL, Alterescu R, Franc B, Goguel AF. Acquired von Willebrand’s syndrome associated with Hairy Cell Leukaemia. Br J Haematol 1980; 46: 503-505
    CrossrefPubMedGoogle Scholar
  • 18 Mazurier C, Parquet-Gernez A, Descamps J, Bauters F, Goudemand M. Acquired von Willebrand’s Syndrome in the Course of Waldenstrom’s Disease. Thromb Haemostas 1980; 44: 115-118
    PubMedGoogle Scholar
  • 19 Vicente V, Alberca I, Prieto J, López Borrasca A. Von Willebrand’s Syndrome associated with von Recklinghausen neurofibromatosis (letter). Blut 1982; 45 (06) 417
    CrossrefPubMedGoogle Scholar
  • 20 Wood GM, Loswsky MS. “Angiodysplasia” of the tongue with acquired von Willebrand’s disease. Postgrad Med J 1982; 58 (675) 37-38
    CrossrefPubMedGoogle Scholar
  • 21 Holland L, Adamson A, Ingram GI C, Chalmers DG. Acquired von Willebrand’s Syndrome. Br J Haematol 1980; 45: 161-164
    CrossrefPubMedGoogle Scholar
  • 22 Pizzuto J, Ambriz R, Reyna MP, Monrroy LM, Morales MR, Aviles A, Conte G, Enriquez R. Acquired von Willebrand’s Syndrome during Autoimmune Disorder. Thromb Haemostas 1979; 42: 1523-1528
    PubMedGoogle Scholar
  • 23 Cass AJ, Bliss BP, Bolton RP, Cooper BT. Gastrointestinal bleeding, angiodysplasia of the colon and acquired von Willebrand’s disease. Br J Surg 1980; 67: 639-641
    CrossrefPubMedGoogle Scholar
  • 24 Gan TE, Sawers RJ, Koutts J. Pathogenesis of Antibody-Induced Acquired von Willebrand Syndrome. Am J Haematol 1980; 9: 363-371
    CrossrefPubMedGoogle Scholar
  • 25 Scott JS, Montgomeri RR, Tubergen DG, Hays T. Acquired von Willebrand’s disease in association with Wilms’ tumor: Regression following treatment. Blood 1981; 58: 665-669
    PubMedGoogle Scholar
  • 26 Gouault-Heilmann M, Dumond MD, Intrator L, Chancal C, Lejonc JL. Acquired von Willebrand syndrome with IgM inhibitor against von Willebrand’s factor. J Clin Pathol 1979; 32: 1030-1035
    CrossrefPubMedGoogle Scholar
  • 27 Meyer D, Zimmerman TS. Von Willebrand’s Disease. In: Haemostasis and Thrombosis. Basic principles and clinical practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. (Eds) J. B. Lippincott Company; Philadelphia: 1982
    Google Scholar
  • 28 Austen DE G, Rhymes IL. A laboratory Manual of Blood Coagulation. Blackwell Scientific Publications; Oxford: 1975
    Google Scholar
  • 29 Schleider MA, Nachman RL, Jaffe EA, Coleman M. A Clinical Study of the Lupus Anticoagulant. Blood 1976; 48: 499-509
    PubMedGoogle Scholar
  • 30 Zimmerman TS, Robert JR, Ruffen ZM. Factor VIII-Related antigen. Characterization by Electrophoretic techniques In: The Hemophilias. Bloom AL. (Ed) Churchill Livingstone; Edinburgh: 1982
    Google Scholar
  • 31 Levy-Toledano S, Bredoux R, Rendu F, Jeanneau C, Saranian E, Dassin E. Isolement et fonctions de plaquettes. Nou Rev Fr Hematol 1976; 16: 368-372
    PubMedGoogle Scholar
  • 32 Allain JP, Frommel D. Antibodies to Factor VIII. I. Variations in Stability of Antigen-Antibody Complexes in Hemophilia A. Blood 1973; 42: 437-444
    PubMedGoogle Scholar
  • 33 Allain JP, Gaillandre A, Frommel D. Acquired Haemophilia: Functional Study of Antibodies to Factor VIII. Thromb Haemostas 1981; 45: 285-289
    PubMedGoogle Scholar
  • 34 Kasper C. A more uniform measurement of factor VIII inhibitors. Thrombos Diathes Haemorrh 1975; 34: 869-872
    PubMedGoogle Scholar
  • 35 Conard J. Inhibitors of blood coagulation. In: Blood Coagulation and Haemostasis. A practical guide. Thomson JM. (Ed.) Churchill Livingstone; Edinburgh: 1980
    Google Scholar
  • 36 Jones TC. Cestodes (Tapeworms). In: Principles and Practice of Infectious Diseases. Mandell GL, Douglas RG, Bennett JE. (Eds.) John Wiley & Sons; New York: 1979
    Google Scholar
  • 37 Shoenfeld Y, Rauch J, Massicotte H, Datta SK, André-Schwarts J, Stollar BD, Schwarts RS. Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Eng J Med 1983; 308: 414-419
    CrossrefPubMedGoogle Scholar
  • 38 Carreras LO, Machin SJ, Deman R, Defreyn G, Vermylen J, Spitz B. Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244-246
    PubMedGoogle Scholar